Total trials
103
Active
10
Phase 3
3
Total enrollment
10,081
Pipeline matrix
Showing 11 of 11 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Liposomal bupivacaine | — | — | — | — | — | 2 | |
| Etomidate | — | — | — | — | — | 1 | |
| Propofol | — | — | — | — | — | 1 | |
| Ropivacaine | — | — | — | — | — | 1 | |
| Bupivacain | — | — | — | — | — | 1 | |
| Bupivacaine Hcl 0.25% Inj | — | — | — | — | — | 1 | |
| Liposomal Bupivicaine/Bupivacaine Admixture | — | — | — | — | — | 1 | |
| Bupivacaine HCL | — | — | — | — | — | 1 | |
| High THC/No CBD Marihuana | — | — | — | — | — | 1 | |
| High THC/High CBD Marihuana | — | — | — | — | — | 1 | |
| No THC/No CBD Marihuana | — | — | — | — | — | 1 |
Next readouts
- 2025-11
- 2025-12
- 2026-10-30
- 2026-12-30
- 2026-12-30
Top conditions
- Obesity7
- Coronary Artery Disease5
- Diabetes5
- Pelvic Organ Prolapse5
- Wound Infection4
- Healthy Volunteers4
- Suicide, Attempted3
- Myocardial Ischemia3
Frequently asked questions about Hartford Hospital
- How many clinical trials does Hartford Hospital have on ClinicalTrials.gov?
- Hartford Hospital is listed as the lead sponsor on 103 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hartford Hospital's trials are in Phase 3?
- 3 of Hartford Hospital's trials are in Phase 3, spread across 11 active drug programs.
- What therapeutic areas does Hartford Hospital focus on?
- Hartford Hospital's most-studied conditions on ClinicalTrials.gov are Obesity, Coronary Artery Disease, Diabetes, Pelvic Organ Prolapse, Wound Infection.
- When are Hartford Hospital's next clinical trial readouts?
- Hartford Hospital has 5 upcoming primary-completion readouts tracked here; the soonest is “Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy”, expected around 2025-11.